Landmark Arthritis Health Report Has Consumers Seeking Flexoplex

Share Article

A recent health report has shown that there may be a blood test in the works that can diagnose RA (rheumatoid arthritis) and other forms of the disease early on—promoting consumer awareness for effective preventative and all-natural treatment supplements for arthritis, like Flexoplex.

A recently published health report that suggests there may be a simple blood test in the works over the years to come that would enable people to learn if they are at risk from suffering from arthritis, and what preventative measures and lifestyle changes they could incorporate to minimize such risks of contracting this disease, have been the caveat of consumer awareness in the first quarter—prompting an influx in sales of Pharmaxa Labs’ all-natural bone, joint and ligament supplement – for treating and preventing the symptoms of arthritis – Flexoplex.

In a late January article that was published on the popular health website,, the article revealed a landmark arthritis study that could enable people to be able to test for RA (rheumatoid arthritis) using a blood test early on—long before the disease sets in—so they could better prepare for it, or even stave it off by taking early preventative measures and incorporating the proper lifestyle changes.

The article cites,
“A new study published in ‘Arthritis and Rheumatism’ suggests that signs of rheumatoid arthritis may present in the blood years before symptoms arise. Inflammatory proteins called cytokines, which are known to be present in synovial tissue after rheumatoid arthritis develops, appear to reach elevated levels in the tissue years before the condition manifests.
While there is no cure for RA, knowing it is coming would be of enormous benefit, allowing sufferers to prepare in advance so that when the RA sets in they can lead more active lifestyles.”
(Source: Internet, 2010;

Early prevention and treatment is the key, according to Flexoplex spokesperson, Jerry Coleman.

“It is heartening to see such avid and candid developments in modern medicine, where in the years to come people will be able to take a simple blood test and easily find out if they are genetically prone to such terrible diseases,” Coleman states.

Since, according to medical experts, prevention is the precursor when it comes to arthritis, and treatment is the aftereffect, Coleman strongly feels that Flexoplex has much to offer.

“No matter whether you find out that you are genetically prone to suffering from this disease later on, or you have already been diagnosed, with few medical treatments on the table – and costly ones at that – it is nice to know that you can find the relief you seek in a safe, all-natural and side effect-free, easy-to-take daily supplement such as Flexoplex,” Coleman adds.

Flexoplex is an all-natural and side effect-free supplement which contains clinically-proven ingredients that was designed to help prevent and treat arthritis.

It is one of the only all-natural arthritis supplements currently on the market.

Most people report noticeable signs of improvement within the first thirty to ninety days of daily usage.

Learn more about Flexoplex by visiting:

About Flexoplex:

  •     Developed Pharmaxa Labs—a leading nutraceutical company
  •     Helps rebuild worn joints
  •     Lubricates stiff joints
  •     Increases range of motion
  •     Improves mobility and flexibility
  •     Soothes inflamed joints
  •     Decreases pain associated with arthritis
  •     Protects the production of naturally-occurring “pain killers” (endorphins and enkephalins)
  •     Maintains healthy bones and joints for aging individuals
  •     Improves blood supply and provides healing nutrients to surrounding tissues and cartilages
  •     Stimulates the synthesis of synovial fluid and the complete matrix of the cartilage
  •     Uses clinically-proven ingredients
  •     100% safe, effective and all-natural
  •     Visit them online for generous discounts off retail pricing and to learn more at:


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Liz Gilman
Visit website